Immune checkpoint markers in gastroenteropancreatic neuroendocrine neoplasia

Florian Bösch(Universitätsmedizin Göttingen), Thomas Knösel(LMU Klinikum)
Endocrine Related Cancer
January 3, 2019
10.1530/erc-18-0494
Cited by 83

Related Papers

Google Goes Cancer: Improving Outcome Prediction for Cancer Patients by Network-Based Ranking of Marker Genes
|PLoS Computational Biology|2012|216
VISTA in Soft Tissue Sarcomas: A Perspective for Immunotherapy?
|Cancers|2022|6
TIM-3 Qualifies as a Potential Immunotherapeutic Target in Specific Subsets of Patients with High-Risk Soft Tissue Sarcomas (HR-STS)
|Cancers|2023|4